Diallyl trisulfide alleviates dextran sulphate sodium‐induced colitis in mice by inhibiting NLRP3 inflammasome activation via ROS/Trx‐1 pathway.

MLA

He, Yue, et al. “Diallyl Trisulfide Alleviates Dextran Sulphate Sodium‐induced Colitis in Mice by Inhibiting NLRP3 Inflammasome Activation via ROS/Trx‐1 Pathway.” Basic & Clinical Pharmacology & Toxicology, vol. 135, no. 5, Nov. 2024, pp. 593–606. EBSCOhost, https://doi.org/10.1111/bcpt.14083.

APA

He, Y., Xiao, L., Zhang, J., Zhu, Y., Guo, Y., Xia, Y., Zhao, H., Wei, Z., & Dai, Y. (2024). Diallyl trisulfide alleviates dextran sulphate sodium‐induced colitis in mice by inhibiting NLRP3 inflammasome activation via ROS/Trx‐1 pathway. Basic & Clinical Pharmacology & Toxicology, 135(5), 593–606. https://doi.org/10.1111/bcpt.14083

Chicago

He, Yue, Ling Xiao, Jing Zhang, Yanrong Zhu, Yilei Guo, Yufeng Xia, Huatou Zhao, Zhifeng Wei, and Yue Dai. 2024. “Diallyl Trisulfide Alleviates Dextran Sulphate Sodium‐induced Colitis in Mice by Inhibiting NLRP3 Inflammasome Activation via ROS/Trx‐1 Pathway.” Basic & Clinical Pharmacology & Toxicology 135 (5): 593–606. doi:10.1111/bcpt.14083.